Semaglutide dose may matter more than weight loss for heart health
A large real-world study suggests semaglutide’s cardiovascular benefits may be more closely linked to the dose patients receive…
People judge weight loss more harshly when GLP-1 drugs are involved, study finds
Even when medication is paired with diet and exercise, people may still feel their weight loss is less…
Genetic study shows dual GIPR/GLP1R action curbs binge alcohol use
New genetic evidence suggests that targeting GIPR and GLP1R could reduce harmful drinking patterns while improving liver and…
GLP1 agonists linked to depression risk in new genetic study
A groundbreaking study published in the journal Current Neuropharmacology highlights a concerning potential link between Glucagon-like Peptide-1 (GLP1) receptor agonists-widely…